Skip to main content

Table 1 Baseline HIV-1 drug resistance mutations in the study population

From: A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

  1. Primary resistance mutations (Wensing, 2017) are underlined
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us